Anderson, MD, MAS, an assistant professor of medicine from the University of Pittsburgh, clinical trials of several GLP-1 receptor agonists like semaglutide (Wegovy/Ozempic, Novo Nordisk) for weight loss included exclusion criteria of chronic medical and psychiatric conditions. However, [FDA] labeling does not restrict these treatments in these populations, they wrote in JAMA Internal Medicine
Your job is to educate them responsibly
Some people taking GLP-1 drugs say theyre more sensitive to alcohols negative effects
Incorporate regular exercise into your routine, including both cardio and strength training
Further, an overview of the prescribing information and recommendations on GLP-1 RA use in T2DM management from diabetic associations across the world is presented
Peptides are short chains of amino acids that send messages to skin cells, telling them to make more collagen or heal faster